Introduction
Hill and Scott (1964) first described the successful use of cyclophosphamide in the treatment of a patient with systemic lupus erythematosus (S.L.E.) who had failed to respond to steroids. Their results were confirmed by Seah et al. (1966) and Hadidi (1970) . Similarly, Cameron et al. (1970) successfully treated three cases of lupus nephritis with cyclophosphamide. In experimental studies, Russell and Hicks (1968) showed that cyclophosphamide in appropriate doses decreased the incidence of severe spontaneous autoimmune renal disease from 100% to 67% in female (NZB and NZW) Medical Unit, Thomson Road General Hospital, Toa Payoh Rise, Singapore 11 P. H. FENG, M.R.C.P.GLASG., Consultant Physician Medical Unit HI, Outram Road General Hospital, Singapore 3 F. J. JAYARATNAM, F.R.A.C.P., Consultant Physician C. S: SEAH, F.R.C.P., F.R.A.C.P., Head and Senior Physician Department of Pathology, University of Singapore E. P. C. TOCK, M.D., M.C.P.A., Associate Professor of Pathology Fl hybrid mice. It appears, therefore, that cyclophosphamide could be a useful drug in the long-term management of S.L.E. We report here our experience with cyclophosphamide in the management of S.L.E. over a seven-year period. The patients originally reported on by Seah et al. (1966) are included.
Patients and Methods Forty-two patients were studied. All fulfilled the criteria for S.L.E. as proposed by Dubois (1966) . Thirty-seven patients were female and five were male, again showing the preponderance of females over males. Age at onset varied from 15 to 62 years, but was mostly (71 % of cases) between 15 and 30 years. A positive L.E. phenomenon was found in 83%, hypergammaglobulinaemia in 80%, and a raised E.S.R. (more than 40 mm in one hour) in 85 % of the patients. Fiftyfive per cent, were anaemic (haemoglobin less than 10 g/100 ml), 30% had thrombocytopenia (platelets less than 100,000/ mm3), and 25 % had leucopenia (W.B.C. less than 4,000/ mm3). Abnormalities in the urine were found in 77% of the patients, and six presented with the features of classical nephrotic syndrome. Altogether 40 renal biopsies were carried out in 31 patients.
All the patients were admitted to the medical unit at Thomson Road General Hospital. Biochemical tests were carried out as described previously (Seah et al., 1966) . Patients with severe constitutional symptoms were given prednisolone 60-30 mg daily, and those with minor systemic disturbances were started on prednisolone 15 mg a day. As soon as improvement occurred the dose of prednisolone was gradually decreased and cyclophosphamide was instituted. Initially this was given intravenously as a single weekly dose of 400 mg, but after discharge oral tablets were substituted, the dosage being 100 mg four times a week. All patients reported regularly to the follow-up clinic and cyclophosphamide was continued unless the total white cell count fell below 3,000/mm,3 when the drug was stopped for one week. Treatment was terminated when severe side effects occurred. Small doses of steroids were maintained in some cases. All biochemical tests were repeated at six-monthly intervals.
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Results
The period of treatment after initiation of cyclophosphamide therapy extended from six to 84 months, with an average follow-up period of 34 months. The response to treatment was rated as (1) very good-complete remission of clinical and biochemical abnormalities; (2) good-n-inimal clinical and/ or biochemical abnormalities but patients able to lead a normal life; and (3) poor-minimal or no improvement, with patients leading a restricted life.
The therapeutic response is summarized in table I. There were six deaths in the series, two from renal failure, three from cerebral involvement, and one from cryptococcal meningitis with terminal uraemia. (Pollak et al., 1964; Wilson et al., 1963) renal biopsies formed an important part of this study. Thirty-one patients who had clinical evidence of renal involvement in the form of either microscopical haematuria or significant proteinuria, or both, or gave their consent were biopsied before treatment. Seven of these patients had repeat biopsies about a year after treatment. The results were categorized by one of us (E.P.C.T.) according to the criteria of Pollak and Pirani (Dubois, 1966) +20MnhV.Go for two years. Amenorrhoea also occurred in some patients with the nephrotic syndrome treated with cyclophosphamide, as reported previously (Feng, 1972) .
Discussion
Since 1952, when the use of corticotrophin and cortisone in S.L.E. was first described (Dubois et al., 1952; Soffer and Bader, 1952) , steroids have remained the comerstone of therapy in this disease. Different regimens have been used (Pollak et al., 1961; Zweiman et al., 1968) . In a disease which is so protean in its manifestation and variable in its course and prognosis (Rowell, 1969) 
